Jackson Square Partners, LLC Bio Techne Corp Transaction History

Jackson Square Partners, LLC

  • $2.38 Billion
  • Q1 2024

A detailed history of Jackson Square Partners, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Jackson Square Partners, LLC holds 1,076,099 shares of TECH stock, worth $83.1 Million. This represents 3.18% of its overall portfolio holdings.

Number of Shares
1,076,099
Previous 1,497,086 28.12%
Holding current value
$83.1 Million
Previous $116 Million 34.43%
% of portfolio
3.18%
Previous 3.78%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
SELL
$65.98 - $77.09 $27.8 Million - $32.5 Million
-420,987 Reduced 28.12%
1,076,099 $75.7 Million
Q4 2023

Feb 08, 2024
BUY
$52.83 - $78.22 $12.5 Million - $18.5 Million
236,539 Added 18.76%
1,497,086 $116 Million
Q3 2023

Nov 13, 2023
SELL
$67.52 - $89.42 $6.84 Million - $9.05 Million
-101,242 Reduced 7.43%
1,260,547 $85.8 Million
Q2 2023

Aug 11, 2023
SELL
$73.76 - $85.98 $9.09 Million - $10.6 Million
-123,278 Reduced 8.3%
1,361,789 $111 Million
Q1 2023

May 11, 2023
SELL
$71.62 - $86.62 $31.7 Million - $38.3 Million
-442,074 Reduced 22.94%
1,485,067 $110 Million
Q4 2022

Feb 09, 2023
BUY
$80.67 - $352.29 $113 Million - $495 Million
1,405,150 Added 269.19%
1,927,141 $160 Million
Q3 2022

Nov 14, 2022
SELL
$282.54 - $391.85 $9.65 Million - $13.4 Million
-34,166 Reduced 6.14%
521,991 $148 Million
Q2 2022

Aug 12, 2022
SELL
$322.67 - $449.65 $7.93 Million - $11.1 Million
-24,586 Reduced 4.23%
556,157 $193 Million
Q1 2022

May 13, 2022
SELL
$353.85 - $487.79 $7.28 Million - $10 Million
-20,586 Reduced 3.42%
580,743 $251 Million
Q4 2021

Feb 14, 2022
SELL
$456.15 - $525.06 $35.1 Million - $40.4 Million
-76,995 Reduced 11.35%
601,329 $311 Million
Q3 2021

Nov 12, 2021
SELL
$444.87 - $538.88 $57.6 Million - $69.7 Million
-129,429 Reduced 16.02%
678,324 $329 Million
Q2 2021

Aug 13, 2021
SELL
$387.35 - $450.26 $53.3 Million - $61.9 Million
-137,525 Reduced 14.55%
807,753 $364 Million
Q1 2021

May 13, 2021
SELL
$314.62 - $411.0 $4.26 Million - $5.57 Million
-13,551 Reduced 1.41%
945,278 $361 Million
Q4 2020

Feb 12, 2021
SELL
$246.9 - $321.87 $7 Million - $9.13 Million
-28,364 Reduced 2.87%
958,829 $304 Million
Q3 2020

Nov 13, 2020
SELL
$232.22 - $282.96 $2.5 Million - $3.04 Million
-10,747 Reduced 1.08%
987,193 $245 Million
Q2 2020

Aug 07, 2020
BUY
$185.43 - $279.56 $556,104 - $838,400
2,999 Added 0.3%
997,940 $264 Million
Q1 2020

May 13, 2020
BUY
$161.17 - $221.51 $2.41 Million - $3.32 Million
14,984 Added 1.53%
994,941 $189 Million
Q4 2019

Feb 13, 2020
BUY
$189.68 - $222.09 $13 Million - $15.2 Million
68,434 Added 7.51%
979,957 $215 Million
Q3 2019

Nov 12, 2019
BUY
$183.56 - $216.72 $442,563 - $522,511
2,411 Added 0.27%
911,523 $178 Million
Q2 2019

Aug 14, 2019
BUY
$188.72 - $215.43 $5 Million - $5.7 Million
26,478 Added 3.0%
909,112 $190 Million
Q1 2019

May 14, 2019
BUY
$136.09 - $200.44 $4.54 Million - $6.69 Million
33,357 Added 3.93%
882,634 $175 Million
Q4 2018

Feb 13, 2019
BUY
$132.75 - $203.8 $5.86 Million - $9 Million
44,156 Added 5.48%
849,277 $123 Million
Q3 2018

Nov 09, 2018
SELL
$147.44 - $204.11 $2.03 Million - $2.82 Million
-13,799 Reduced 1.69%
805,121 $164 Million
Q2 2018

Aug 13, 2018
SELL
$144.9 - $165.58 $13.1 Million - $15 Million
-90,602 Reduced 9.96%
818,920 $121 Million
Q1 2018

May 14, 2018
SELL
$131.46 - $151.04 $2.88 Million - $3.3 Million
-21,878 Reduced 2.35%
909,522 $137 Million
Q4 2017

Feb 13, 2018
BUY
$121.17 - $134.75 $8.46 Million - $9.4 Million
69,784 Added 8.1%
931,400 $121 Million
Q3 2017

Nov 14, 2017
BUY
$113.59 - $123.78 $97.9 Million - $107 Million
861,616
861,616 $104 Million

Others Institutions Holding TECH

# of Institutions
581
Shares Held
154M
Call Options Held
180K
Put Options Held
189K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.03B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Jackson Square Partners, LLC Portfolio

Follow Jackson Square Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email